z-logo
open-access-imgOpen Access
Efficacy and safety of Reduning injection in the treatment of COVID-19: a randomized, multicenter clinical study
Author(s) -
Xiaolong Xu,
Junhua Zhang,
Wenke Zheng,
Zifeng Yang,
Xuegong Zhao,
ChangFeng Wang,
Hongzheng Su,
Zhao Li,
Leyang Xue,
Fen Hu,
Xiaohong Xu,
Minyong Wen,
Jiong Liao,
Zhaohai Zeng,
Liping Wang,
Jiaqing Zeng,
Yuhong Guo,
Bo Li,
Qingquan Liu
Publication year - 2021
Publication title -
annals of palliative medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.546
H-Index - 19
eISSN - 2224-5839
pISSN - 2224-5820
DOI - 10.21037/apm-20-2121
Subject(s) - medicine , covid-19 , clinical endpoint , randomized controlled trial , clinical trial , clinical efficacy , pneumonia , surgery , disease , infectious disease (medical specialty)
Reduning injection is a traditional Chinese medicine (TCM) with known efficacy against a variety of viral infections, but there is no data about its efficacy against coronavirus disease 2019 (COVID-19).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom